{"id":24988,"date":"2025-08-29T16:37:00","date_gmt":"2025-08-29T14:37:00","guid":{"rendered":"https:\/\/investx.fr\/de\/?p=24988"},"modified":"2025-08-29T13:37:55","modified_gmt":"2025-08-29T11:37:55","slug":"krypto-reserven-mei-pharma-insiderhandel-analyse","status":"publish","type":"post","link":"https:\/\/investx.fr\/de\/krypto-news\/krypto-reserven-mei-pharma-insiderhandel-analyse\/","title":{"rendered":"Krypto-Reserven: MEI Pharma & Insiderhandel-Risiken? Analyse"},"content":{"rendered":"\n

Kryptok\u00e4ufe durch Unternehmen: Segen oder Falle f\u00fcr Anleger?<\/h2>\n\n\n\n

B\u00f6rsennotierte Unternehmen, die massive Krypto<\/a>-K\u00e4ufe<\/strong> f\u00fcr ihre Reserven ank\u00fcndigen, sehen oft, wie ihre Aktien in den Tagen zuvor in die H\u00f6he schnellen. Ein Trend, der Bedenken<\/strong> hinsichtlich m\u00f6glicher Insidergesch\u00e4fte in einer noch stark regulierten Branche aufkommen l\u00e4sst.<\/p>\n\n\n\n

\n

MEI Pharma became the first public US company to adopt a Litecoin Treasury Strategy.

929,548
$LTC<\/a> were acquired for ~$100M at ~$107.58 per token.

Thanks to the involvement of
@SatoshiLite<\/a> & @GSR_io<\/a>, we're bringing the people's currency to institutional portfolios.$MEIP<\/a> pic.twitter.com\/EuRDtfse8m<\/a><\/p>— MEI Pharma (@MEI_Pharma) August 14, 2025<\/a><\/blockquote>